Janus kinase inhibitors for the treatment of COVID‐19

Overview of attention for article published in Cochrane database of systematic reviews, June 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 1 news outlet
blogs: 3 blogs

twitter: 53 X users
facebook: 1 Facebook page

Citations

dimensions_citation: 37 Dimensions

Readers on

mendeley: 122 Mendeley

Summary News Blogs X Facebook Dimensions citations

So far, Altmetric has seen 1 news story.

Scientists evaluate JNK inhibitors in treating moderate to severe COVID-19 patients

The Medical News, 22 Jun 2022

Janus kinase (JNK) inhibitors with antiviral and anti-inflammatory properties have shown promising outcomes in treating…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.